STOCK TITAN

BWX Technologies, Inc. - BWXT STOCK NEWS

Welcome to our dedicated page for BWX Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on BWX Technologies stock.

BWX Technologies, Inc. (BWXT) is a premier provider of nuclear components and fuel to the U.S. government. The company is renowned for its technical expertise, management, and site services, supporting government operations of complex facilities and environmental remediation activities. BWXT also plays a critical role in the commercial nuclear power industry, offering precision-manufactured components and specialized services.

Headquartered in Lynchburg, Virginia, BWXT has a significant presence with operations in Erwin, Tennessee; Mount Vernon, Indiana; Euclid, Ohio; Barberton, Ohio; Cambridge, Ontario, Canada; and over a dozen U.S. Department of Energy sites around the country. It employs more than 5,200 skilled professionals dedicated to advancing nuclear technology and safety.

BWXT operates in two main segments: Government Operations and Commercial Operations. The Government Operations segment encompasses the legacy Nuclear Operations Group and Nuclear Services Group, focusing on advanced reactor projects and innovative manufacturing techniques. The Commercial Operations segment includes the legacy Nuclear Power Group, which engages in research, development, and commercialization of medical and industrial radioisotopes and radiopharmaceuticals.

The company’s financial health is robust, with a majority of its revenue generated from its Government Operations segment. BWXT’s strategic partnerships and projects aim to enhance its market presence and technological capabilities. Geographically, while the company operates in the United States, Canada, and the United Kingdom, the bulk of its revenue comes from the United States.

Recent achievements highlight BWXT's commitment to innovation and excellence. The company continues to secure significant contracts, invest in cutting-edge technologies, and expand its services in the nuclear sector. These efforts underscore BWXT’s pivotal role in both government and commercial nuclear projects.

Rhea-AI Summary

Fusion Pharmaceuticals and BWXT Medical have established a preferred partner agreement for the supply of actinium-225, enhancing Fusion's existing isotope supply for its clinical-stage radiopharmaceuticals. This strategic partnership is poised to support growing demand for targeted alpha therapies (TATs) while ensuring volume-based pricing. The collaboration emphasizes BWXT's commitment to meeting the global actinium supply needs, bolstering Fusion's clinical programs and future business opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
partnership
-
Rhea-AI Summary

BWX Technologies, Inc. (NYSE: BWXT) announced the promotion of Ronald O. (Chip) Whitford, Jr. to senior vice president, general counsel, and chief compliance officer, effective January 2, 2023. He succeeds Thomas E. McCabe, who will transition to a special advisor role until his retirement on August 1, 2023. Whitford, with a background in legal affairs spanning multiple industries, has been with BWXT since 2017. This move is part of the company’s succession planning strategy, ensuring continuity in its legal and compliance functions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
-
Rhea-AI Summary

BWX Technologies (NYSE: BWXT) has marked a significant breakthrough with the production of TRISO nuclear fuel, celebrated alongside officials from the U.S. Department of Defense, Department of Energy, NASA, and Idaho National Laboratory. This fuel, noted for its robustness, will power the first U.S. microreactor under Project Pele with a $37 million grant from Idaho National Laboratory. BWXT aims to enhance energy resilience, enabling clean energy objectives and support for military and disaster responses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.37%
Tags
none
Rhea-AI Summary

BWX Technologies reported a strong third quarter 2022, with revenue of $523.7 million and a net income of $61.8 million or $0.67 EPS. The commercial operations segment grew by 22%, while overall revenue increased by 5% compared to the previous year. Adjusted EBITDA stood at $100.1 million. The company has narrowed its 2022 earnings guidance but anticipates revenue and EBITDA growth in 2023, supported by key nuclear projects and FDA acceptance of its technetium-99m generator application for priority review.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
none
-
Rhea-AI Summary

BWX Technologies, Inc. (NYSE: BWXT) announced participation in three investor conferences before year-end. Key events include:

  • Nov. 9: Baird Global Industrial Conference, Chicago.
  • Dec. 1: Credit Suisse 10th Annual Global Industrial Conference, Manalapan, Florida.
  • Dec. 6: Truist Securities Industrials and Services Summit, New York City.

Executives attending include CEO Rex Geveden, CFO Robb LeMasters, and VP of Investor Relations Mark Kratz. For further details about BWXT, visit their website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
conferences
-
Rhea-AI Summary

BWX Technologies, Inc. (NYSE: BWXT) has finalized an amended and restated credit agreement with Wells Fargo and other lenders, enhancing its liquidity and revising critical terms. The new agreement includes a $250 million Term A Loan, maturing on Oct. 12, 2027, to repay existing borrowings under a $750 million Revolving Credit Facility, also extended to the same maturity date. Key terms adjusted allow netting of up to $100 million in cash assets, improving financial flexibility, according to CFO Robb LeMasters.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
none
Rhea-AI Summary

BWX Technologies, Inc. (NYSE: BWXT) will announce its third quarter 2022 results on November 7, 2022, after market close. A conference call will follow at 5:00 p.m. EST. Investors can access the presentation online at www.bwxt.com/investors. BWXT is a leading provider of nuclear solutions for various sectors including security and clean energy, operating with approximately 6,700 employees across 14 major sites in the U.S., Canada, and the U.K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.17%
Tags
none
-
Rhea-AI Summary

BWX Technologies, Inc. (NYSE: BWXT) announced that its subsidiary, BWXT Medical Ltd., has submitted a new drug application to the U.S. FDA for its technetium-99m (Tc-99m) generator used in diagnostic imaging. This proprietary technology will process molybdenum-99 (Mo-99) at an Ontario Power Generation reactor, aiming to provide a lower-cost, reliable alternative to current generators. Tc-99m is pivotal in over 40 million diagnostic procedures annually. The company is optimistic about future growth opportunities in therapeutic radioisotopes and expanding its product portfolio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.28%
Tags
none
-
Rhea-AI Summary

BWX Technologies, Inc. (NYSE: BWXT) has appointed Robert Duffy as senior vice president and chief administrative officer, effective August 29, 2022. Duffy brings extensive experience from his prior role at Harris Corporation, overseeing human resources, supply chain, and operational improvements. He replaces Rick Loving, who is retiring after 43 years with the company. Duffy’s leadership is expected to support BWXT's growth in core and new nuclear markets as noted by CEO Rex Geveden.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
none
Rhea-AI Summary

BWX Technologies, Inc. reported a strong second quarter 2022 with revenue of $554 million, up 10% year-over-year. GAAP net income reached $74.6 million or $0.82 per diluted share, a 32% increase. Adjusted EBITDA stood at $114.7 million, a 26% rise from the previous year. The company has increased its 2022 guidance for revenue, adjusted EBITDA, and capital expenditures while narrowing its non-GAAP EPS guidance. Key developments include completing Tc-99m reference batches and commencing work on the first advanced microreactor for the Department of Defense.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
none

FAQ

What is the current stock price of BWX Technologies (BWXT)?

The current stock price of BWX Technologies (BWXT) is $115.24 as of January 30, 2025.

What is the market cap of BWX Technologies (BWXT)?

The market cap of BWX Technologies (BWXT) is approximately 10.4B.

What does BWX Technologies, Inc. (BWXT) specialize in?

BWXT specializes in providing nuclear components and fuel to the U.S. government, supporting complex facility operations, and offering services to the commercial nuclear power industry.

Where is BWXT headquartered?

BWXT is headquartered in Lynchburg, Virginia.

How many employees does BWXT have?

BWXT employs more than 5,200 professionals.

What are the main segments BWXT operates in?

BWXT operates in two main segments: Government Operations and Commercial Operations.

Which segment contributes the most to BWXT's revenue?

The Government Operations segment contributes the most to BWXT's revenue.

Where does BWXT have significant operations?

BWXT has significant operations in Virginia, Tennessee, Indiana, Ohio, and Ontario, as well as at over a dozen U.S. Department of Energy sites.

What are BWXT's recent achievements?

BWXT has secured significant contracts, invested in advanced technologies, and expanded its services in the nuclear sector.

What industries does BWXT serve?

BWXT serves the government, commercial nuclear power, medical, and industrial sectors.

Does BWXT operate internationally?

Yes, BWXT operates in the United States, Canada, and the United Kingdom, with the majority of its revenue coming from the United States.

What kind of services does BWXT provide?

BWXT provides technical, management, and site services for complex facility operations and environmental remediation, along with precision manufacturing for commercial nuclear power.
BWX Technologies, Inc.

Nasdaq:BWXT

BWXT Rankings

BWXT Stock Data

10.42B
91.09M
0.38%
93.75%
1.28%
Aerospace & Defense
Engines & Turbines
Link
United States of America
LYNCHBURG